Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | AQUA PHARMA | Awarded | 1 | ₹4,800 |
| 2 | Schedule 2 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITED | Awarded | 1 | ₹4,650 |
| 3 | Schedule 3 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITED | Awarded | 1 | ₹274.50 |
| 4 | Schedule 4 | SUNIL PHARMACY | Awarded | 1 | ₹684 |
| 5 | Schedule 5 | arihant pharma | Awarded | 1 | ₹3,105 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
20 Jan 2026, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
product 1
product 2
product 3
product 4
product 5
product 6
product 7
product 8
product 9
product 10
8774715
GEM/2025/B/7054448
Two Packet Bid
product 1
21 days
Leh
Item wise evaluation
BOQ
6 documents required · 6 mandatory
3 yrs
₹31
₹2 L
50%
Exempted
20 Jan 2026
30 Dec 2025
20 Jan 2026
ANTI PHLEBITIS CREAM TUBE OF 15g/20g
LUMBOSACRAL BELT SUPPORT (SIZE S/M/L/XL/XXL)
BUPIVACAINE HCL 5 mg/mI 20 ml INJ
ONDANSETRON (2mg/ml) 4ml Inj
RANITIDINE 150 mg TAB
ORNIDAZOLE 500mg + OFLOXACIN 200mg
OMEPRAZOLE 20mg
MAGNESIUM SULPHATE 50% w/v Inj
SUCCINYLCHLOLINE CHLORIDE 50 mg/ml
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8774715.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
med_-1_2025-12-29-18-19-31_15b1f1c7f67559f6b1e984c862bf4939.pdf
BOQ
med_2_2025-12-29-18-19-31_64ef122ab27cea2012609d1d65066f04.csv
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .